BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19732125)

  • 21. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
    Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
    Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma.
    Verma A; Shukla NK; Deo SV; Gupta SD; Ralhan R
    Oncology; 2005; 68(4-6):462-70. PubMed ID: 16024937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of p16 and p16 beta in squamous epithelial carcinomas and adenocarcinomas of the esophagus: differences in regulation dependent on kind of tumor and histology].
    Metzger R; Danenberg K; Hayashi K; Hölscher AH; Danenberg PV
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):491-4. PubMed ID: 14518304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].
    Liu JL; Zhou BJ; Zhang Y; Wu YP; Liu SZ; G A O WM; Xue J; Liu WH
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):689-92. PubMed ID: 18246800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of MCM4 in esophageal cancer].
    Huang XP; Zhang X; Su XD; Ma GW; Zhao JM; Rong TH
    Ai Zheng; 2007 Jan; 26(1):96-9. PubMed ID: 17222376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
    Kita Y; Mimori K; Iwatsuki M; Yokobori T; Ieta K; Tanaka F; Ishii H; Okumura H; Natsugoe S; Mori M
    Ann Surg Oncol; 2011 Jan; 18(1):261-72. PubMed ID: 20734150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
    Hayashi K; Metzger R; Salonga D; Danenberg K; Leichman LP; Fink U; Sendler A; Kelsen D; Schwartz GK; Groshen S; Lenz HJ; Danenberg PV
    Oncogene; 1997 Sep; 15(12):1481-8. PubMed ID: 9333024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of ezrin in esophageal squamous cell carcinoma.
    Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
    J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression.
    Kazemi-Noureini S; Colonna-Romano S; Ziaee AA; Malboobi MA; Yazdanbod M; Setayeshgar P; Maresca B
    World J Gastroenterol; 2004 Jun; 10(12):1716-21. PubMed ID: 15188492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma.
    Liu HC; Zhang Y; Wang XL; Qin WS; Liu YH; Zhang L; Zhu CL
    Biomed Pharmacother; 2013 Oct; 67(8):751-5. PubMed ID: 23725757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
    Greenawalt DM; Duong C; Smyth GK; Ciavarella ML; Thompson NJ; Tiang T; Murray WK; Thomas RJ; Phillips WA
    Int J Cancer; 2007 May; 120(9):1914-21. PubMed ID: 17236199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma.
    Hiramatsu T; Osaki M; Ito Y; Tanji Y; Tokuyasu N; Ito H
    Pathobiology; 2005; 72(6):316-24. PubMed ID: 16582583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.
    Lo PH; Xie D; Chan KC; Xu FP; Kuzmin I; Lerman MI; Law S; Chua D; Sham J; Lung ML
    Cancer Lett; 2007 Nov; 257(2):199-205. PubMed ID: 17720308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma.
    Wang Q; Lu J; Yang C; Wang X; Cheng L; Hu G; Sun Y; Zhang X; Wu M; Liu Z
    Cancer Lett; 2002 May; 179(1):71-7. PubMed ID: 11880184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma.
    Chung JY; Braunschweig T; Hu N; Roth M; Traicoff JL; Wang QH; Knezevic V; Taylor PR; Hewitt SM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1403-8. PubMed ID: 16835344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.